IG Farben

Insights on the Security Printing Global Market to 2027 - by Function, Application and Region

Retrieved on: 
Wednesday, December 22, 2021
Printing, Forecasting, Function, IDS, Technology, Digital printing, Patient, Security, IG Farben, LLC, Corruption, Growth, BFSI, Industry, Government, Document, COVID-19, Computer, Intaglio, Internet, Awareness, Lithography, Global, Application, CAGR, Letterpress printing, Animal, Security printing, Cryptocurrency, Insurance

The Global Security Printing Market size is expected to reach $3.8 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period.

Key Points: 
  • The Global Security Printing Market size is expected to reach $3.8 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period.
  • Security printing includes holograms, copying marks, security threads, watermarks, anti-magnetic inks, serial numbers, micro-printing, special paper, and intaglio printing.
  • Additionally, security printing ensures the necessary aspects of protection due to which several computer systems are dependent on it.
  • Based on Function, the market is segmented into Lithographic Printing, Digital Printing, Letterpress Printing, Screen Printing, Intaglio Printing and Others.

Bayer Fund Teams with Farmers to Direct Funds to Local Nonprofits, Schools and Ag Programs

Retrieved on: 
Monday, August 2, 2021
Companies, Industry economics), Aspirin, Bayer, IG Farben, Leverkusen, Economy of Germany

For 2022, Bayer Fund will double the individual donations to $5,000, up from $2,500 in previous years.

Key Points: 
  • For 2022, Bayer Fund will double the individual donations to $5,000, up from $2,500 in previous years.
  • America's Farmers initiatives have awarded more than $60 million to thousands of schools and nonprofit organizations.
  • "We can't thank our local farmers and the Grow Communities program enough for their donation and continued support," said Beth Burrow, Greenfield High School's ag instructor.
  • America's Farmers, sponsored by Bayer Fund, is focused on strengthening rural America through community outreach programs that partner with farmers to make an impact in communities where farmers live and work.

Bayer Provides Update on Path to Closure of Roundup™ Litigation

Retrieved on: 
Thursday, July 29, 2021
Legal, Chemicals, Plastics, Professional services, Manufacturing, Other Health, Health, General Health, Other Science, Science, Companies, Herbicides, Articles, Aspirin, Bayer, IG Farben, Leverkusen, Industry economics), Roundup, Forward-looking statement

Bayer today provided an update on its five-point plan to address future Roundup litigation risk after its May 27th decision to withdraw from the national class process.

Key Points: 
  • Bayer today provided an update on its five-point plan to address future Roundup litigation risk after its May 27th decision to withdraw from the national class process.
  • The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation.
  • However, Bayer is also prepared for the second scenario to manage anticipated claims, through settlement and litigation, to ultimately bring an end to this litigation.
  • The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Fears Nachawati Trial Lawyers Challenge Bayer AG's Latest Bid to Reduce Weed Killer Liabilities

Retrieved on: 
Thursday, July 29, 2021
Companies, Industry economics), Life sciences, Aspirin, Bayer, IG Farben, Leverkusen, Seed companies, Monsanto, Denial

Despite Judge Chhabria's ruling, Bayer AG again sought to limit its potential liabilities by entering into another purported class-action settlement, this time in federal district court in Delaware.

Key Points: 
  • Despite Judge Chhabria's ruling, Bayer AG again sought to limit its potential liabilities by entering into another purported class-action settlement, this time in federal district court in Delaware.
  • His rulings, including his recent denial of Bayer's settlement proposal, have exposed the flaws and shortcomings of the company's legal strategy," Fears Nachawati co-founder Majed Nachawati said.
  • "There are more than 50,000 cases nationwide that remain unresolved and would remain so if this company had its way," Mr. Nachawati continued.
  • "This latest move is a transparently obvious attempt for Monsanto to subvert Judge Chhabria's denial of the future class."

Denise Vitola Joins Bayer Communications Team

Retrieved on: 
Monday, July 26, 2021
General Health, Other Retail, Social media, Pharmaceutical, Discount, Variety, Supermarket, Retail, Public relations, Investor relations, Marketing, Advertising, Biotechnology, Communications, Health, Companies, Aspirin, Bayer, IG Farben, Leverkusen, Industry economics), Communication design, Articles, WE, Brand

Bayer today announced Denise Vitola is joining the Bayer Communications Team as Vice President of Brand Integration, PR, Social and Influencer for Consumer Health.

Key Points: 
  • Bayer today announced Denise Vitola is joining the Bayer Communications Team as Vice President of Brand Integration, PR, Social and Influencer for Consumer Health.
  • Vitola will report to Beth Roden, SVP and Head of Communications Bayer U.S. and Head of Communications, Consumer Health North America.
  • Denise will also be a member of the U.S. Corporate Communications Leadership Team, driving reputation, digital excellence and integrated communications.
  • We are thrilled she is now officially a member of the Bayer Communications team and will continue to drive our successful integrated communications that has been an essential part of reaching our consumers and driving awareness of our brands.

BlueRock Therapeutics Announces New Board Chair, New President and CEO

Retrieved on: 
Monday, July 26, 2021
Companies, Industry economics), Aspirin, Bayer, IG Farben, Leverkusen, Economy of Germany

CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of BayerAG, announcedtodaythat Emile Nuwaysir, Ph.D., current President and CEO, will transition to the position of BlueRock Board Chair, effective August 1, 2021.

Key Points: 
  • CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of BayerAG, announcedtodaythat Emile Nuwaysir, Ph.D., current President and CEO, will transition to the position of BlueRock Board Chair, effective August 1, 2021.
  • Current Chief Scientific Officer Seth Ettenberg, Ph.D., will assume the role of President and CEO.
  • BlueRock will continue in its mission to create authentic cellular medicines to reverse devastating diseases and improve the human condition.
  • BlueRock also recently initiated a first-of-its-kind trial of pluripotent stem-cell derived dopaminergic neurons in patients with advanced Parkinson's disease.

BASF CEO Martin Brudermuller to Receive 2021 ICIS CEO of the Year Award

Retrieved on: 
Thursday, July 22, 2021
BASF, IG Farben, Societates Europaeae, The Holocaust, ICIS, ICIS, Companies, Economy of Germany, Industry economics)

LONDON and NEW YORK, July 22, 2021 /PRNewswire/ -- The ICIS CEO of the Year Award will be presented toDr.

Key Points: 
  • LONDON and NEW YORK, July 22, 2021 /PRNewswire/ -- The ICIS CEO of the Year Award will be presented toDr.
  • Martin Brudermller, Chief Executive Officer of BASF, for outstanding achievement as voted on and recognised by his peers in the ICIS Top 40 Power Players.
  • Brudermller at the ICIS Power Players Awards virtual event on 22 September.
  • The event will include a fireside chat with ICIS on BASF's strategy and outlook, along with key industry trends such as sustainability and decarbonisation.

BASF CEO Martin Brudermuller to Receive 2021 ICIS CEO of the Year Award

Retrieved on: 
Thursday, July 22, 2021
BASF, IG Farben, Societates Europaeae, The Holocaust, ICIS, ICIS, Companies, Economy of Germany, Industry economics)

LONDON and NEW YORK, July 22, 2021 /PRNewswire/ -- The ICIS CEO of the Year Award will be presented toDr.

Key Points: 
  • LONDON and NEW YORK, July 22, 2021 /PRNewswire/ -- The ICIS CEO of the Year Award will be presented toDr.
  • Martin Brudermller, Chief Executive Officer of BASF, for outstanding achievement as voted on and recognised by his peers in the ICIS Top 40 Power Players.
  • Brudermller at the ICIS Power Players Awards virtual event on 22 September.
  • The event will include a fireside chat with ICIS on BASF's strategy and outlook, along with key industry trends such as sustainability and decarbonisation.

Ada expands its global leadership team to help drive company's rapid growth

Retrieved on: 
Thursday, July 15, 2021
Companies, Industry economics), Life sciences, Aspirin, Bayer, IG Farben, Leverkusen, Pharmaceutical industry in China

Earlier this year, the company announced a $90 million Series B investment led by Leaps by Bayer to further accelerate this growth.

Key Points: 
  • Earlier this year, the company announced a $90 million Series B investment led by Leaps by Bayer to further accelerate this growth.
  • I am thrilled to be joining the team at Ada, and look forward to further shaping the company's already extraordinary success and growth alongside the team."
  • Prior to Ada, Lemari spent over fifteen years working with Bayer Pharmaceuticals, holding various Global and Regional leadership roles across Pharma Commercial Operations.
  • The Ada platform has 11 million users worldwide, and has completed 23 million assessments since its global launch in 2016.

Ada expands its global leadership team to help drive company's rapid growth

Retrieved on: 
Thursday, July 15, 2021
Companies, Industry economics), Life sciences, Aspirin, Bayer, IG Farben, Leverkusen, Pharmaceutical industry in China

Earlier this year, the company announced a $90 million Series B investment led by Leaps by Bayer to further accelerate this growth.

Key Points: 
  • Earlier this year, the company announced a $90 million Series B investment led by Leaps by Bayer to further accelerate this growth.
  • I am thrilled to be joining the team at Ada, and look forward to further shaping the company's already extraordinary success and growth alongside the team."
  • Prior to Ada, Lemari spent over fifteen years working with Bayer Pharmaceuticals, holding various Global and Regional leadership roles across Pharma Commercial Operations.
  • The Ada platform has 11 million users worldwide, and has completed 23 million assessments since its global launch in 2016.